D-K6L9 is an all-D enantiomeric peptide enriched in lysine and leucine residues arranged for amphipathic helix formation. D-configuration confers strong resistance to proteolysis while preserving membrane-interaction potential. Researchers explore its folding, aggregation, and antimicrobial-like properties in vitro. Applications include D-peptide design, stability studies, and membrane-active motif development.
CAT No: R2793
CAS No:426264-61-1
Synonyms/Alias:D-K6L9; 426264-61-1; HY-P5924A; DA-62931; CS-0896345;
D-K6L9 is a synthetic antimicrobial peptide engineered with a D-amino acid configuration, which imparts enhanced stability against proteolytic degradation compared to its L-amino acid counterparts. Characterized by its amphipathic helical structure and cationic charge, D-K6L9 exhibits broad-spectrum activity against a variety of microbial organisms, including both Gram-positive and Gram-negative bacteria. Its unique sequence design allows it to interact effectively with microbial membranes, leading to rapid disruption and cell death. Due to these features, D-K6L9 has garnered significant interest in both academic and industrial research as a promising tool for investigating antimicrobial mechanisms, developing new anti-infective strategies, and exploring peptide-membrane interactions.
Antimicrobial Research: D-K6L9 serves as a valuable model compound for studying the mechanisms underlying antimicrobial peptide activity. Researchers utilize it in vitro to examine how cationic peptides interact with bacterial membranes, disrupt membrane integrity, and induce cell lysis. The peptide's resistance to enzymatic degradation makes it particularly useful in experiments requiring prolonged incubation or exposure to protease-rich environments. By comparing the activity of D-K6L9 with that of traditional L-amino acid-based peptides, scientists can elucidate the structural and functional determinants responsible for antimicrobial efficacy and stability. These insights are instrumental in guiding the rational design of next-generation antimicrobial agents.
Biofilm Inhibition Studies: In the context of biofilm research, D-K6L9 is frequently employed to assess its ability to prevent biofilm formation or to eradicate established biofilms. Biofilms pose significant challenges in both clinical and industrial settings due to their resistance to conventional antibiotics and disinfectants. The peptide's capability to penetrate and disrupt biofilm matrices provides a model system for evaluating anti-biofilm strategies and for screening potential adjuvants that enhance peptide efficacy. Studies involving D-K6L9 contribute to a deeper understanding of the physicochemical factors that govern peptide-biofilm interactions and inform the development of surface coatings or materials with intrinsic antimicrobial properties.
Membrane Biophysics: D-K6L9 is widely used in membrane biophysics to investigate the biophysical interactions between peptides and lipid bilayers. Its amphipathic nature and defined secondary structure make it an ideal probe for exploring membrane perturbation, pore formation, and lipid phase transitions. Techniques such as fluorescence spectroscopy, circular dichroism, and atomic force microscopy leverage the peptide to reveal the dynamics of membrane disruption at the molecular level. These studies not only advance fundamental knowledge of peptide-membrane interactions but also provide a platform for comparing the effects of D- versus L-amino acid substitutions on peptide function.
Peptide Engineering and Design: The robust properties of D-K6L9 make it a reference standard in peptide engineering efforts aimed at enhancing stability, selectivity, and activity. Researchers employ it as a scaffold to introduce sequence modifications, test novel amino acid substitutions, and evaluate the impact on antimicrobial potency and resistance profiles. The insights gained from such structure-activity relationship studies are crucial for optimizing peptide therapeutics and for developing synthetic analogs tailored to specific research or industrial applications. Additionally, D-K6L9's performance in various biological assays informs computational modeling and high-throughput screening approaches designed to accelerate peptide discovery.
Surface Functionalization: D-K6L9 is increasingly utilized for the functionalization of biomaterials and medical devices to impart antimicrobial properties. By covalently attaching the peptide to surfaces such as polymers, metals, or hydrogels, researchers can create coatings that resist microbial colonization and biofilm development. The stability of the D-amino acid configuration ensures prolonged activity, making it suitable for long-term applications in environments prone to contamination. These functionalized materials are evaluated in laboratory models to assess their efficacy, durability, and compatibility with other surface treatments, contributing to advancements in infection-resistant technologies.
Peptide-based research continues to evolve, and D-K6L9 remains at the forefront as a versatile tool for advancing our understanding of antimicrobial mechanisms, biofilm dynamics, membrane interactions, peptide design, and material science. Its unique structural features and broad applicability underscore its value in both fundamental and applied research, supporting innovation in fields ranging from microbiology to biomedical engineering.
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.